Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126651372 | 12665137 | 2 | F | 2016 | 20160817 | 20160818 | 20160826 | PER | US-CELGENEUS-USA-2016083929 | CELGENE | 0.00 | M | Y | 70.82000 | KG | 20160826 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126651372 | 12665137 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | B2014AC | 20785 | 200 | MG | CAPSULES | QD | |||||
| 126651372 | 12665137 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | B2014AC | 20785 | 50 | MG | CAPSULES | QD | |||||
| 126651372 | 12665137 | 3 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | B2014AC | 20785 | 100 | MG | CAPSULES | QD | |||||
| 126651372 | 12665137 | 4 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | Unknown | 0 | 17 | G | UNKNOWN | ||||||||
| 126651372 | 12665137 | 5 | C | ZOMETA | ZOLEDRONIC ACID | 1 | Unknown | 4MG/100ML | 0 | UNKNOWN | |||||||||
| 126651372 | 12665137 | 6 | C | DIGITEK | DIGOXIN | 1 | Oral | 0 | 125 | UG | TABLETS | ||||||||
| 126651372 | 12665137 | 7 | C | Potassium | POTASSIUM | 1 | Unknown | 0 | 99 | MG | UNKNOWN | ||||||||
| 126651372 | 12665137 | 8 | C | PENICILLIN V POTASSIUM. | PENICILLIN V POTASSIUM | 1 | Unknown | 17 GRAM | 0 | UNKNOWN | |||||||||
| 126651372 | 12665137 | 9 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126651372 | 12665137 | 10 | C | Calcium-magnesium | CALCIUMMAGNESIUM | 1 | Unknown | 125 MICROGRAM | 0 | UNKNOWN | |||||||||
| 126651372 | 12665137 | 11 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 99 MILLIGRAM | 0 | 4 | MG | TABLETS | |||||||
| 126651372 | 12665137 | 12 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | .5 | MG | UNKNOWN | ||||||||
| 126651372 | 12665137 | 13 | C | LORATADINE D | LORATADINEPSEUDOEPHEDRINE SULFATE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126651372 | 12665137 | 1 | Plasma cell myeloma |
| 126651372 | 12665137 | 4 | Product used for unknown indication |
| 126651372 | 12665137 | 5 | Product used for unknown indication |
| 126651372 | 12665137 | 6 | Product used for unknown indication |
| 126651372 | 12665137 | 7 | Product used for unknown indication |
| 126651372 | 12665137 | 8 | Product used for unknown indication |
| 126651372 | 12665137 | 9 | Product used for unknown indication |
| 126651372 | 12665137 | 10 | Product used for unknown indication |
| 126651372 | 12665137 | 11 | Product used for unknown indication |
| 126651372 | 12665137 | 12 | Product used for unknown indication |
| 126651372 | 12665137 | 13 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126651372 | 12665137 | Constipation | |
| 126651372 | 12665137 | Cough | |
| 126651372 | 12665137 | Diarrhoea | |
| 126651372 | 12665137 | Flatulence | |
| 126651372 | 12665137 | Lung disorder | |
| 126651372 | 12665137 | Prostatic disorder | |
| 126651372 | 12665137 | Upper-airway cough syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126651372 | 12665137 | 1 | 20160328 | 0 | ||
| 126651372 | 12665137 | 2 | 201605 | 0 | ||
| 126651372 | 12665137 | 3 | 201608 | 0 |